Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2006
12/20/2006CN1879688A Preparation for treating wind-heat type cold, its preparation process and quality control method
12/20/2006CN1879617A Modulating multiple lineage kinase proteins
12/20/2006CN1291291C Resistance welding method
12/20/2006CN1291231C Method for detecting specificities of activated lymphocyte
12/20/2006CN1291230C Process for chemical modification of microcapsule algal toxin LR and complete antigen synthesis
12/20/2006CN1291229C Method for separating and detecting urine protein by capillary electrophoretic chip
12/20/2006CN1291228C Equipment and method for determining the physical and chemical change in biological sample
12/20/2006CN1291040C Gene sequencing tech. of exon 19-21 deletion variation of epidermal growth factor receptor in free serum DNA
12/20/2006CN1291039C Process for extracting prokaryotic microorganism DNA in sample and special reagent thereof
12/20/2006CN1291036C Biomolecule microarry preparation method and siting apparatus
12/20/2006CN1290855C Nucleotide analogs with six-membered rings
12/20/2006CN1290580C Chick lecithal immune globulin products against rolavirus
12/19/2006USRE39436 Interventions to mimic the effects of calorie restriction
12/19/2006USRE39433 Therapeutic agents as cytokine antagonists and agonists
12/19/2006US7151606 Method for evaluation of vegetables and fruits and evaluation apparatus therefor
12/19/2006US7151598 Method and apparatus for enhanced nano-spectroscopic scanning
12/19/2006US7151383 Oil condition sensor
12/19/2006US7151301 Sensitivity enhanced biomolecule field effect transistor
12/19/2006US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma
12/19/2006US7151164 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases
12/19/2006US7151160 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2006US7151082 Administering an effective amount of an antagonist or inhibitor of high mobility group 1 protein (HMG1) for therapy of condition characterized by activation of the inflammatory cytokine cascade
12/19/2006US7151047 Stable, water-soluble quantum dot, method of preparation and conjugates thereof
12/19/2006US7151000 Serum is treated with a complexing agent which agent binds prions in the sample forming an agent/protein complex which makes it possible to concentrate the complex
12/19/2006US7150997 Electrode array assembly formed on integrated circuit chip; includes row decoder, column decoder, counter coupled to decoders, matrix of active biologic electrodes, memory, and digital to analog converter; monitoring reactions
12/19/2006US7150996 Stability assessment of dispersions and emulsions
12/19/2006US7150995 quantitative measurement of percent glycated hemoglobin as hemoglobin A1c in whole blood comprising a blood dilution solution and a device adapted for receiving at least a portion of diluted blood solution; blood dilution solution is not in contact with the dry immunoassay reagent system during storage
12/19/2006US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006US7150976 Regulation of human serine-threonine protein kinase
12/19/2006US7150974 Parathyroid hormone receptor binding method
12/19/2006US7150973 Methods and kits for purifying his-tagged proteins
12/19/2006US7150972 biologically active polypeptide capable of intracellular cholesterol transport in mosquitoes; target for development of agents with insecticidal activities
12/19/2006US7150971 Membrane-resident steroid receptors and methods of use thereof
12/19/2006US7150967 Uisng fluorescent label; mercurimethyl dihydropsoralen
12/19/2006US7150966 Determining whether fluorescently labeled compound is phosphorylated via monitoring/measuring shift in polarized fluorescence
12/19/2006US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/19/2006US7150859 Sample is selectively and simultaneously deposited on chips at predetermined corresponding locations by electro-spraying
12/19/2006US7150858 Compact analyzer which is capable of efficiently analyzing a single kind of sample at a time.
12/19/2006US7150857 For adequately correcting data in accordance with the deterioration of a reagent over time
12/19/2006US7150856 On-spot selectively activated hydrophobic slide and preparation thereof
12/19/2006US7150834 Multiple laminar flow-based rate zonal or isopycnic separation with holographic optical trapping of blood cells and other static components
12/19/2006US7150398 Multi-angle laser scanner
12/19/2006US7150183 Compositional characterization and quantification of solid deposits from hydrocarbon fluids
12/19/2006US7150182 High throughput screening methods for lubricating oil compositions
12/19/2006US7150179 Impact sensor for detecting an impact of a collision
12/19/2006US7150178 Golf ball COR testing machine
12/19/2006CA2402537C Quality control material for reagentless measurement of analytes
12/19/2006CA2373682C Method and measuring arrangement for measuring paper surface
12/19/2006CA2321726C Method for determination of an irreversible stretch and of a dynamic modulus of elasticity
12/19/2006CA2297547C An improved method for preparing dna from serum and plasma
12/19/2006CA2251058C Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone h1
12/19/2006CA2211218C Ball and socket closure
12/19/2006CA2200423C Novel estrogen receptor
12/19/2006CA2154013C Analytical element, composition and method using modified apo-horseradish peroxidase
12/18/2006CA2550170A1 Glucose analysis instrument
12/17/2006CA2550171A1 Sensor system as well as an arrangement and method for monitoring a constituent and in particular glucose in body tissue
12/16/2006CA2550321A1 Procedure for the standardization of coagulation tests
12/14/2006WO2006133460A2 Methods for diagnosing and treating breast cancer based on a her/er ratio
12/14/2006WO2006133423A1 Methods and composition for diagnosis of neurological disorders in body fluids
12/14/2006WO2006133420A2 Treatment of patients with cancer therapy
12/14/2006WO2006133408A2 Breast cancer and prostate cancer assessment
12/14/2006WO2006133399A1 METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES
12/14/2006WO2006133325A2 Analysis of tissue samples surrounding malignancies
12/14/2006WO2006133192A2 Generation and use of a catalog of polypeptide-related information for chemical analyses
12/14/2006WO2006133171A2 Biosensor strips and methods of preparing same
12/14/2006WO2006133164A2 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006WO2006133145A2 Tat-007 and methods of assessing and treating cancer
12/14/2006WO2006133109A1 Methods and apparatus for fractionation-based chemical analyses
12/14/2006WO2006133107A2 Specific binding sites in collagen for integrins and use thereof
12/14/2006WO2006133103A2 Reservoir for delivery of agents
12/14/2006WO2006133016A2 Method for analyzing biological data sets
12/14/2006WO2006133013A2 Methods of generating protein variants with altered function
12/14/2006WO2006132994A2 System and method for absolute quantitation of proteins using lc/ms
12/14/2006WO2006132809A2 Monoclonal antibody reagents
12/14/2006WO2006132791A1 Method of manufacturing a disposable diagnostic meter
12/14/2006WO2006132683A2 Reagents and methods for use in cancer diagnosis, classification and therapy
12/14/2006WO2006132666A1 Assays based on liquid flow over arrays
12/14/2006WO2006132635A1 Hand-held fluorescence polarimeter
12/14/2006WO2006132587A1 Tumour marker in brca2 associated breast cancer
12/14/2006WO2006132476A1 Dual-function surface plasmon resonance biosensor system
12/14/2006WO2006132446A1 Method of manufacturing probe-immobilized carrier
12/14/2006WO2006132445A2 A pharmaceutical composition for treating and diagnosing a disorder associated with peroxisomal biogenesis and function
12/14/2006WO2006132401A1 Method for evaluation of compound using rsk1
12/14/2006WO2006132352A1 Pharmaceutical composition containing sc(fv)2
12/14/2006WO2006132326A1 Method for immobilizing vital cell and sensor for measuring vital cell activation function
12/14/2006WO2006132324A1 Reaction container and reaction apparatus employing the same
12/14/2006WO2006132294A1 Structure, porous body, sensor, process of structure and detecting method for specimen
12/14/2006WO2006132248A1 Method for ubiquitination of runx
12/14/2006WO2006132116A1 Cell electric physiology measurement device and method of manufacturing the same
12/14/2006WO2006132074A1 Method for replacing liquid, method for extracting component by using it, composite container and automatic analyzer
12/14/2006WO2006132041A1 Specimen sampling liquid container
12/14/2006WO2006132030A1 Novel compound, reagent comprising the compound for peptide or protein analysis, and method of analysis with the analytical reagent
12/14/2006WO2006131750A2 Lipase polypeptide
12/14/2006WO2006131679A2 Planar device with well addressing automated by dynamic electrowetting
12/14/2006WO2006131676A2 Method for detecting encephalopathies
12/14/2006WO2006131562A2 Diagnostic and therapeutic target cdc2l6 gene and proteins for neurodegenerative diseases
12/14/2006WO2006131529A1 Use of nt-proanp and nt-probnp for diagnosing cardiac diseases
12/14/2006WO2006131512A2 Anti-thrombotic agents
12/14/2006WO2006131400A1 Diagnostic-nanosensor and its use in medicine
12/14/2006WO2006131389A1 Receptor in dendritic cells